Stock price Biogen Idec Inc (BIIB) today

Biogen Inc. is an American multinational biotechnology corporation engaged in the research and development of drugs for the treatment of hematology, neurodegenerative and autoimmune diseases. Biogen was founded in Geneva in 1978. In 2003, it merged with the pharmaceutical giant IDEC, followed by a new company, whose name was changed to Biogen Idec, became the third largest biotechnology company in the world, and subsequently the company name was returned to its original version.

After the IPO, the company's stocks are a component of indices such as the S & P 100, S & P 500, S & P 1500 and NASDAQ-100. Throughout its existence, Biogen has actively acquired both entire companies and the rights to individual drugs.

Biogen has a market capitalization of more than $ 63 billion.